Direct answer: Written sell rules prevent emotional decision-making at the moment it is most costly. For serious investors ages 6-12, sell rules fall into three categories: thesis invalidation (the reason you bought the security no longer holds), valuation (the price has reached or exceeded your estimate of fair value), and portfolio management (the position has grown to exceed concentration limits or rebalancing requires trimming). Define these rules before entering any position.
Sell Rules and Thesis Invalidation for Investors Ages 6-12
Category 1: Thesis Invalidation
Every equity position should have an explicit thesis: a one-paragraph description of why you bought the security, what conditions would have to hold for the investment to succeed, and what the expected holding period is. Write this down before purchasing. Review it whenever new information arrives about the business.
Thesis invalidation occurs when one or more of the conditions for success has materially changed. Common invalidation signals: the competitive moat has eroded (a new entrant with significantly lower costs, a technological shift that makes the company's offering less relevant), management has changed in a way that undermines the investment case (new CEO with a track record of value destruction, departure of the analyst or founder whose insights drove the thesis), or a structural shift in the business model (moving from a high-margin subscription model to a low-margin transactional model).
For accounts managed on behalf of children ages 6-12, exit rules apply to any individual equity positions in the research sleeve. For index fund positions (the core), exit rules do not apply in the conventional sense: you hold the index fund until you need the money or until the asset class allocation changes. The parent managing the account should write exit rules for any individual stock position the same way they would for their own account.
When the thesis is invalidated, the sale should be made regardless of the current price relative to cost. Anchoring to cost basis is the most common behavioral error: a position that has lost 30% and whose underlying thesis is invalidated will likely lose more. The purchase price is a sunk cost. The relevant question is always: knowing what I know now, would I buy this at the current price? If the answer is no, the exit rule applies.
Category 2: Valuation Targets
Before entering a position, establish a fair value estimate. When the price reaches or exceeds that estimate, the expected return from the current price is no longer attractive. This is a sell signal.
A simple valuation exit: if the P/E ratio has expanded well above the company's long-term historical average or its peers without a corresponding improvement in growth or quality, the valuation premium is the risk rather than the opportunity. Trimming or exiting at rich valuations captures the value created by the appreciation and redeploys it into more attractively priced opportunities.
Valuation exits should be partial for tax efficiency. Selling 50% of a winning position that has reached fair value captures half the gain for redeployment while retaining exposure if the thesis continues to play out. This is particularly relevant in taxable accounts where the sale creates a taxable event: a partial exit manages the tax bill while still acting on the valuation signal.
Category 3: Portfolio Management Rules
Portfolio management exits occur not because the thesis is broken or the stock is overvalued, but because the position has grown to a size that creates concentration risk or rebalancing requires trimming. These are the most emotionally difficult exits because the position has typically performed well to reach the concentration threshold.
Define the concentration threshold in advance (typically 5-10% of total portfolio). When any position crosses that threshold, trim back to the target weight. This is a rule, not a judgment call. The rule prevents the post-hoc rationalization that always accompanies a winner: "it went to 12% of the portfolio, but it's such a great company that I'll let it ride."
Asset class rebalancing also drives exits in a portfolio management context. When the research sleeve as a whole exceeds its target percentage (for example, 12% actual versus 10% target), trim back to target by selling the least compelling positions in the sleeve. This is a disciplined counterpart to the thesis-invalidation sale: the position may still be valid and fairly valued, but the portfolio structure requires trimming.
Frequently Asked Questions
What is the most common sell-rule mistake?
Anchoring to cost basis. Investors hold losing positions far too long because selling would "lock in the loss." The loss already exists in the portfolio; selling simply converts an unrealized loss to a realized one (which, in a taxable account, creates a tax benefit through tax-loss harvesting). The question is never whether the current price is above or below the purchase price. It is always: given everything known today, is this the best use of this capital?
Should exit rules be different for a research sleeve versus an index fund?
Yes. Index fund exits are driven by asset allocation decisions, not individual security analysis. You sell an index fund when rebalancing requires it or when you need the cash. Individual positions in the research sleeve have specific thesis-based and valuation-based exit rules in addition to concentration limits. Do not apply thesis-based exit logic to index funds (they have no individual company thesis to invalidate), and do not hold individual stocks indefinitely the way you would an index fund.
Is this personalized financial advice?
No. Content here is educational and cannot know a reader's complete finances, taxes, legal situation, risk capacity or goals. Use qualified professionals for individualized investment, tax or legal advice when needed.